Antibiotic plan guided by infection tracking in cirrhosis
Part of Infections clinical trials.
This study compares standard antibiotic treatment versus antibiotic choices guided by local infection tracking (epidemiological surveillance) in people with cirrhosis who have an acute worsening and likely a bacterial infection. It may help doctors choose antibiotics more accurately and safely in this high-risk situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have cirrhosis with a sudden worsening (acute decompensation)
- You have a proven or suspected bacterial infection that needs antibiotics based on the hospital’s usual rules
- The infection is newly diagnosed—treated as not ongoing for more than 48 hours
- You are not currently in intensive care (ICU) for this illness
- You have not had a drug-resistant (MDR) bacterial infection or colonization in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study measures how antibiotic drugs called beta-lactams work in people with cirrhosis (liver damage). Researchers will check antibiotic blood levels to see if standard doses are right for cirrhotic patients or need adjustment.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This study tests whether adding a probiotic to standard antibiotics helps treat an infection in the abdominal fluid of people with cirrhosis (called spontaneous bacterial peritonitis) and prevents it from coming back.
This study looks at how doctors can better monitor antibiotic levels in the blood of intensive care patients with severe infections (sepsis or septic shock). The goal is to see if adjusting antibiotic doses based on these levels improves recovery.
This study looks at how doctors can best manage antibiotics for a common type of blood infection (caused by Enterobacterales bacteria like E. coli). If you join, your treatment will be carefully guided to make sure you get the right antibiotics at the right time, which may help you recover faster and prevent antibiotic resistance.
Hear when a new Decompensated Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.